Eagle Pharmaceuticals Inc
(EGRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 35,642 | -8,627 | 11,989 | 14,313 | 31,903 |
| Depreciation Amortization | 13,736 | 5,278 | 5,185 | 5,131 | 4,046 |
| Income taxes - deferred | -8,324 | -3,618 | -1,511 | 152 | -2,468 |
| Accounts receivable | -30,832 | 9,529 | -3,113 | 18,481 | -12,665 |
| Accounts payable and accrued liabilities | 2,966 | 10,162 | 806 | -4,455 | -2,064 |
| Other Working Capital | -16,404 | 9,537 | 816 | 14,392 | -7,889 |
| Other Operating Activity | 53,917 | 5,958 | 35,325 | 7,972 | 41,521 |
| Operating Cash Flow | $50,701 | $28,219 | $49,497 | $55,986 | $52,384 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | -5,000 | N/A | N/A | N/A |
| PPE Investments | -178 | -323 | -747 | -777 | -133 |
| Net Acquisitions | -74,152 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -12,500 | 0 | -17,500 | N/A | N/A |
| Investing Cash Flow | $-86,830 | $-5,323 | $-18,247 | $-777 | $-133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 80,000 | N/A | 110,000 | N/A | N/A |
| Debt Repayment | -67,236 | -8,000 | -115,000 | -6,000 | -3,750 |
| Common Stock Issued | 1,747 | 2,398 | 3,654 | 260 | 8,615 |
| Common Stock Repurchased | -18,004 | -21,213 | -34,999 | -17,961 | -73,105 |
| Other Financing Activity | -2,716 | -1,577 | -1,525 | -524 | -19,877 |
| Financing Cash Flow | $-6,209 | $-28,392 | $-37,870 | $-24,225 | $-88,117 |
| Beginning Cash Position | 97,659 | 103,155 | 109,775 | 78,791 | 114,657 |
| End Cash Position | 55,321 | 97,659 | 103,155 | 109,775 | 78,791 |
| Net Cash Flow | $-42,338 | $-5,496 | $-6,620 | $30,984 | $-35,866 |
| Free Cash Flow | |||||
| Operating Cash Flow | 50,701 | 28,219 | 49,497 | 55,986 | 52,384 |
| Capital Expenditure | -178 | -323 | -747 | -777 | -133 |
| Free Cash Flow | 50,523 | 27,896 | 48,750 | 55,209 | 52,251 |